Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Horby PW., Staplin N., Peto L., Emberson JR., Campbell M., Pessoa-Amorim G., Basnyat B., Thwaites L., Van Doorn R., Hamers RL., Nel J., Amuasi J., Rawal M., Ghosh D., Douse J., Hamilton F., Kerry A., Thu-Ta P., Widdrington J., Green C., Desai P., Stewart R., Phong NT., Baillie JK., Buch MH., Faust SN., Jaki T., Jeffery K., Juszczak E., Knight M., Lim WS., Montgomery A., Mukherjee A., Mumford A., Rowan K., Thwaites G., Mafham M., Haynes R., Landray MJ.

DOI

10.1101/2023.04.13.23288469

Type

Preprint

Publication Date

19/04/2023

Permalink Original publication